Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
Martin C. Tammemägi(National Institutes of Health), Christine D. Berg(National Institutes of Health), Timothy R. Church(University of Minnesota), Gerard A. Silvestri(Dartmouth College), William G. Hocking(Marshfield Clinic), Paul A. Kvale(Henry Ford Health System), Thomas L. Riley(Automation, Information, and Management Systems (United States)), John Commins(National Institutes of Health)
Cited by 361
Related Papers
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
|New England Journal of Medicine|1993|3.3k
Methods for Staging Non-small Cell Lung Cancer
|CHEST Journal|2013|1.5k
The Effect of Fecal Occult-Blood Screening on the Incidence of Colorectal Cancer
|New England Journal of Medicine|2000|1.4k
Selection Criteria for Lung-Cancer Screening
|New England Journal of Medicine|2013|1k
Long-Term Mortality after Screening for Colorectal Cancer
|New England Journal of Medicine|2013|841